Arcadia Biosciences, Inc. — Director's Dealing 2020

Apr 3, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2020-04-01

Reporting Person: Shultz Randall (Chief Technology Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-04-01	Stock Option (Right to Buy)	$2.74	A	18000	Acquired	2030-04-01	Common Stock (18000)	Direct

Footnotes

F1: The option vests in 48 equal installments beginning April 30, 2020 and ending March 31, 2024.